Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

GSK Investigational Site, Lisbon

GSK Investigational Site, Lisbon

GSK Investigational Site, Wellington

GSK Investigational Site, Durham

GSK Investigational Site, Hendersonville

GSK Investigational Site, Alcorcón

GSK Investigational Site, Bordeaux

GSK Investigational Site, New Port Richey

GSK Investigational Site, West Des Moines

GSK Investigational Site, Vandœuvre-lès-Nancy

GSK Investigational Site, Lahore

GSK Investigational Site, St Louis

GSK Investigational Site, Strasbourg

GSK Investigational Site, Duarte

GSK Investigational Site, La Verne

GSK Investigational Site, San Diego

GSK Investigational Site, Fountain Valley

GSK Investigational Site, Villejuif

GSK Investigational Site, Sacramento

GSK Investigational Site, Tacoma

GSK Investigational Site, Moscow

GSK Investigational Site, Tampa

GSK Investigational Site, Boston

GSK Investigational Site, Worcester

GSK Investigational Site, Winnipeg

GSK Investigational Site, St. John's

GSK Investigational Site, Greater Sudbury

GSK Investigational Site, Kitchener

GSK Investigational Site, Bonaventure

GSK Investigational Site, Chandler

GSK Investigational Site, Sherbrooke

GSK Investigational Site, Helsinki

GSK Investigational Site, Kwun Tong

GSK Investigational Site, Lima

GSK Investigational Site, Bialystok

GSK Investigational Site, Lublin

GSK Investigational Site, Olsztyn

GSK Investigational Site, Otwock

GSK Investigational Site, Poznan

GSK Investigational Site, Nottingham